Desloratadine in the Treatment of Seasonal Allergic Rhinitis
- 1 January 2002
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 22 (2) , 43-52
- https://doi.org/10.2165/00044011-200222002-00005
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Exercise and diet reduce risk of diabetes, US study showsPublished by BMJ ,2001
- Desloratadine: A new, nonsedating, oral antihistamineJournal of Allergy and Clinical Immunology, 2001
- Allergy and Allergic DiseasesNew England Journal of Medicine, 2001
- Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H1-Receptor Antagonist, in Patients with Seasonal Allergic RhinitisClinical Drug Investigation, 2001
- Once‐daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled studyInternational Journal of Dermatology, 2001
- Infant Pneumococcal VaccineJAMA, 2000
- The Safety of Newly Approved MedicinesPublished by American Medical Association (AMA) ,1999
- Measuring quality of life in children with rhinoconjunctivitisJournal of Allergy and Clinical Immunology, 1998
- Learning Impairment and Allergic RhinitisAllergy and Asthma Proceedings, 1996
- Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitisClinical and Experimental Allergy, 1991